Creative Details

Quality Score: N/A

Creative Information

CID:46e65ffc-4648-4b4e-ab61-c55de72d52d0
CRID:82_6180-953608
Domain:qxmd.com
Seat:PP
Size:600x531
Bid:$1.70
Timestamp:11/26/2025, 9:13:39 PM
Declared IAB Categories:

    Analysis

    4 succeeded1 failed(80% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysisfailed12/10/2025, 4:27:11 AM0.14s
    adomain_analysissuccess12/10/2025, 5:36:33 AM6.49s
    adomain_capturesuccess12/10/2025, 5:35:55 AM0.11s
    ad_rendersuccess12/10/2025, 4:27:11 AM17.84s
    brand_mappingsuccess11/26/2025, 9:13:39 PM0.10s

    Analysis Results

    Ad Format: native

    Brands: QxMD

    Size:600x531
    Data Transferred:295.93 KB
    Render Time:2.46 Seconds
    Domain Inferred IAB Categories:
    • Education (IAB5)
    • Health & Fitness (IAB7)
    Domain Inferred IAB Ad Products:
    • Medical and Biotechnology (1043)
    • Health and Medical Services (1378)
    Landing Page:
    https://ma2-tr.contextweb.com/bh/ct2?i=XABAOYZYrB3...
    Domain:ma2-tr.contextweb.com
    Brand:
    Internet Archive
    Total Ad Size:295.93 KB
    Requests Made:
    URLSize (KB)
    https://media-active.contextweb.com/creatives/6180/b35b4ea4_ff66_4a6e_bb6a_b41995896c8e_1800x1200_getty_rf_osteosarcoma_bigbead.jpg295.93

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Native Ad

    Patient Outcomes After Elective Discontinuation of Larotrectinib

    Click URL:https://ma2-tr.contextweb.com/bh/ct2?i=X...

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1